Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Abonour · SciRah

Researcher profile · Semantic Scholar

R. Abonour

Share profile

R. Abonour — researcher profile on SciRah

h-index: 41
Works: 357
Citations: 6,788

Most-cited papers

Interim Phase I Clinical Data of FT576 As Monotherapy and in Combination with Daratumumab in Subjects with Relapsed/Refractory Multiple Myeloma
B. Dhakal, J. Berdeja, Tara B. Gregory, T. Ly +9 more
2022Blood54 citations Open access
Semantic Scholar
Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease
S. Farag, M. Abu Zaid, J. Schwartz, Teresa C. Thakrar +5 more
2021New England Journal of Medicine46 citations Open access
Semantic Scholar
Fixed Duration Therapy with Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone for High Risk Smoldering Multiple Myeloma-Results of the Ascent Trial
Shaji K. Kumar, M. Alsina, B. Laplant, A. Badros +9 more
2022Blood40 citations Open access
Semantic Scholar
ASTCT Clinical Practice recommendations for transplant and cellular therapies in multiple myeloma.
B. Dhakal, N. Shah, A. Kansagra, Ambuj Kumar +33 more
2022Transplantation and Cellular Therapy30 citations Open access
Semantic Scholar
Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma.
R. Hájek, J. Minařík, J. Straub, L. Pour +32 more
2021Future Oncology21 citations Open access
Semantic Scholar
MGP Panel is a comprehensive targeted genomics panel for molecular profiling of multiple myeloma patients
Parvathi Sudha, Aarif Ahsan, C. Ashby, T. Kausar +21 more
2022Clinical Cancer Research20 citations Open access
Semantic Scholar
Cryopreservation Preserves Cell-Type Composition and Gene Expression Profiles in Bone Marrow Aspirates From Multiple Myeloma Patients
Duojiao Chen, M. Abu Zaid, J. Reiter, M. Czader +8 more
2021Frontiers in Genetics20 citations Open access
Semantic Scholar
Effect of t (11;14) Abnormality on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect MM Registry.
C. Gasparetto, S. Jagannath, R. Rifkin, B. Durie +13 more
2021Clinical Lymphoma, Myeloma & Leukemia19 citations Open access
Semantic Scholar
High-dose chemotherapy for relapsed testicular germ cell tumours
M. Chovanec, N. Adra, M. Abu Zaid, R. Abonour +1 more
2022Nature reviews. Urology18 citations
Semantic Scholar
Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect® MM Registry
Hans C. Lee, S. Ailawadhi, C. Gasparetto, S. Jagannath +12 more
2021Blood Cancer Journal18 citations Open access
Semantic Scholar
Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT).
F. Taza, R. Abonour, M. Zaid, S. Althouse +5 more
2023Clinical Genitourinary Cancer14 citations
Semantic Scholar
Real-World Treatment Patterns and Clinical Outcomes in Patients With Multiple Myeloma Previously Treated With Lenalidomide and an Anti-CD38 Monoclonal Antibody.
Karthik Ramasamy, Ravi Vij, D. Kuter, David Cella +18 more
2024Clinical Lymphoma, Myeloma & Leukemia11 citations Open access
Semantic Scholar
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma
Travis S. Johnson, Parvathi Sudha, En-Ze Liu, Nathan J. Becker +11 more
2024Nature Communications11 citations Open access
Semantic Scholar
Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients.
M. Thompson, M. Boccadoro, X. Leleu, J. Vela-Ojeda +25 more
2022Clinical Lymphoma, Myeloma & Leukemia10 citations Open access
Semantic Scholar
Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findings From the Connect MM Disease Registry.
Hans C. Lee, K. Ramasamy, K. Weisel, R. Abonour +16 more
2022Clinical Lymphoma, Myeloma & Leukemia10 citations Open access
Semantic Scholar
Identifying novel mechanisms of biallelic TP53 loss refines poor outcome for patients with multiple myeloma
Enze Liu, Parvathi Sudha, Nathan J. Becker, Oumaima Jaouadi +5 more
2023Blood Cancer Journal9 citations Open access
Semantic Scholar
P-008 Idecabtagene vicleucel (ide-cel) vs standard regimens in triple-class–exposed (TCE) relapsed and refractory multiple myeloma (RRMM): KarMMa-3 subgroup analysis in patients receiving bridging therapy
H. Einsele, P. Rodríguez-Otero, B. Arnulf, Krina K. Patel +19 more
2023Clinical Lymphoma, Myeloma & Leukemia8 citations
Semantic Scholar
High‐dose chemotherapy and peripheral blood stem cell transplantation as salvage therapy in primary mediastinal nonseminomatous germ cell tumors: The Indiana University experience
Noah H. Richardson, F. Taza, R. Abonour, S. Althouse +6 more
2024Cancer7 citations Open access
Semantic Scholar
Teclistamab in Relapsed/Refractory Multiple Myeloma: Real-World Outcomes at a Single Academic Center in the Midwest
Adam Stepanovic, R. Abonour, M. Abu Zaid, Sherif S. Farag +2 more
2023Blood7 citations Open access
Semantic Scholar
In-class transition from bortezomib-based therapy to IRd is an effective approach in newly diagnosed multiple myeloma.
R. Rifkin, Caitlin L. Costello, R. Birhiray, S. Kambhampati +10 more
2023Future Oncology6 citations Open access
Semantic Scholar
Prospective Molecular Characterization of Multiple Myeloma Patient Samples Identifies High-Risk Patients and Informs Treatment Sequences through Resistance Mechanisms to Immunotherapies
Phillip Pham, Parvathi Sudha, Lin Wang, Wen Niu +12 more
2023Blood5 citations Open access
Semantic Scholar
Real-world treatment patterns, costs, and outcomes in patients with AL amyloidosis: analysis of the Optum EHR and commercial claims databases
A. Dispenzieri, J. Zonder, J. Hoffman, S. Wong +10 more
2022Amyloid: Journal of Protein Folding Disorders5 citations
Semantic Scholar
Characteristics and Treatment Patterns of Long-surviving Patients With Multiple Myeloma: Over 13 Years of Follow-up in the ConnectⓇ MM Registry.
H. Terebelo, J. Omel, L. I. Wagner, J. Hardin +13 more
2024Clinical Lymphoma, Myeloma & Leukemia4 citations Open access
Semantic Scholar
Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib–lenalidomide–dexamethasone for relapsed/refractory multiple myeloma: A pooled analysis from the INSURE study
Hans C. Lee, Karthik Ramasamy, M. Macro, Faith E. Davies +9 more
2024European Journal of Haematology4 citations Open access
Semantic Scholar
Randomized phase 2 trial of maintenance oral etoposide or observation following high-dose chemotherapy for relapsed metastatic germ cell tumor.
Ryan Ashkar, N. Adra, R. Abonour, M. Abu Zaid +3 more
2022Journal of Clinical Oncology4 citations
Semantic Scholar
Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma
Parvathi Sudha, Travis S. Johnson, Habib Hamidi, Ke Yang +14 more
2025Cancer immunology research3 citations
Semantic Scholar
Utilizing genomics to identify novel immunotherapeutic targets in multiple myeloma high-risk subgroups
En-Ze Liu, Oumaima Jaouadi, Riya Sharma, Nathan J. Becker +9 more
2025bioRxiv3 citations Open access
Semantic Scholar
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry
S. Ailawadhi, Hans C. Lee, J. Omel, K. Toomey +12 more
2024Blood Cancer Journal3 citations Open access
Semantic Scholar
Phase I First-in-Human Study on the Feasibility, Safety, and Antitumor Activity of CD4-Redirected Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with CD4+ T-Cell Malignancies (TCM)
Rita Assi, N. Hagag, Sherif S. Farag, R. Emmons +6 more
2023Blood3 citations Open access
Semantic Scholar
Unraveling Diverse Mechanisms of Complex Structural Variant Interactions through Multiomic Data in Multiple Myeloma
En-Ze Liu, Nathan J. Becker, Parvathi Sudha, A. Mikulasova +5 more
2023Blood3 citations Open access
Semantic Scholar
A Phase 1, Open-Label, Dose-Escalation and Expansion, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MT-0169 in Patients with Relapsed or Refractory Multiple Myeloma or Non-Hodgkin Lymphoma
Bhagirathbhai R. Dholaria, A. Mamuye, Diana Yurewicz, Kristina Dabovic +5 more
2022Blood3 citations Open access
Semantic Scholar
Bispecific T-cell engagers for relapsed/refractory multiple myeloma after solid organ transplantation: A case series
Raul Gregg-Garcia, R. Abonour, A. Suvannasankha
2025Journal of Investigative Medicine2 citations
Semantic Scholar
Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens (SRs) in Triple-Class–Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): KarMMa-3 Subanalysis of Black Patients (pts)
Krina K. Patel, P. Rodríguez-Otero, A. Nooka, Natalie S. Callander +21 more
2024Transplantation and Cellular Therapy2 citations Open access
Semantic Scholar
P-002 Ide-Cel Real-World (RW) and Clinical Trial Long-Term Safety Experience: A Special Focus on Movement and Neurocognitive Treatment Adverse Events (MNT AEs) and Second Primary Malignancies (SPMs)
R. Abonour, Amani Kitali, A. Gipson, A. Trovato +7 more
2024Clinical Lymphoma, Myeloma & Leukemia2 citations
Semantic Scholar
P925: IMPACT OF PRIOR TREATMENT EXPOSURE ON THE EFFECTIVENESS OF IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED IN ROUTINE CLINICAL PRACTICE (THE INSURE STUDY)
Hans C. Lee, Karthik Ramasamy, M. Macro, Faith E. Davies +10 more
2022HemaSphere2 citations Open access
Semantic Scholar
Healthcare Utilization Among Patients with Advanced Systemic Light Chain Amyloidosis
M. Gertz, R. Abonour, S. Gibbs, M. Finkel +12 more
2022Blood2 citations
Semantic Scholar
MRD in multiple myeloma: From an early endpoint for accelerated approval to MRD driven treatment and clinical management.
O. Landgren, R. Abonour, Dickran Kazandjian
2026Seminars in hematology (Print)1 citations
Semantic Scholar
Diagnostic sequencing identifies high-risk markers and mechanisms of resistance to guide immunotherapy selection
Parvathi Sudha, Phillip Pham, Wen Niu, En-Ze Liu +13 more
2025Blood Advances1 citations Open access
Semantic Scholar
The oligosaccharyltransferase complex is an essential component of multiple myeloma plasma cells
H. Nguyen, En-Ze Liu, A. Q. Le, Mahesh Lamsal +10 more
2025Molecular therapy. Oncology1 citations Open access
Semantic Scholar
Safety and Efficacy of Teclistamab in a Patient Series with Relapsed/Refractory Multiple Myeloma and Severe Renal Impairment on Dialysis
Nutdanai Roila, A. Suvannasankha, R. Abonour
2024Blood1 citations
Semantic Scholar
The Effect of Age and Other Patient Characteristics on Outcomes Among Nontransplanted Patients Who Were Treated With First-Line Lenalidomide, Bortezomib, and Dexamethasone: Results From the ConnectⓇ MM Registry.
R. Abonour, Hans C. Lee, R. Rifkin, S. Ailawadhi +12 more
2024Clinical Lymphoma, Myeloma & Leukemia1 citations
Semantic Scholar
Novel PD-L1 Blocking Peptide with Mitochondrial Targeting Sequence: A Strategy to Counteract Resistance in T-Cell Immunotherapy for Myeloma
Smriti Gurung, C. Crean, D. Halladay, Judith L. Anderson +5 more
2024Blood1 citations
Semantic Scholar
Abstract B010: Systematical evaluation on alternative splicing in immune-related therapy targets reveals innate and acquired therapy resistance mechanisms in multiple myeloma
En-Ze Liu, Travis S. Johnson, Parvathi Sudha, Habib Hamidi +4 more
2024Molecular Cancer Therapeutics1 citations
Semantic Scholar
Multiomics Data Integration in the Complete Myeloma Genome Reveals Frequent Centromeric Rearrangements and Their Epigenomic Consequences
A. Mikulasova, En-Ze Liu, Nathan J. Becker, Parvathi Sudha +2 more
2024Blood1 citations
Semantic Scholar
Characterization of Anthropometric Changes in Patients with Relapsed/Refractory Myeloma Treated with BCMA Bispecific Antibody Teclistamab
Setarah Mohammad Nader, S. T. Jines, Christopher D. Collier, Teresa Zimmers +5 more
2023Blood1 citations
Semantic Scholar
P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI-CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY
R. Abonour, R. Rifkin, S. Ailawadhi, Hans C. Lee +14 more
2023HemaSphere1 citations Open access
Semantic Scholar
Using a Modified Delphi Panel to Estimate Health Service Utilization for Patients with Advanced and Non-Advanced Systemic Light Chain Amyloidosis
Morie Gertz, R. Abonour, S. Gibbs, Muriel Finkel +12 more
2023ClinicoEconomics and Outcomes Research1 citations Open access
Semantic Scholar
P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
R. Rifkin, C. Costello, R. Birhiray, S. Kambhampati +10 more
2022HemaSphere1 citations Open access
Semantic Scholar
A Clinically Validated Targeted Capture Panel to Identify Translocations, Copy Number Abnormalities, and Mutations in Multiple Myeloma
Parvathi Sudha, Aarif Ahsan, A. Khera, Mohammad H. Kazeroun +21 more
2021Blood1 citations
Semantic Scholar
Genomic characterization of patient derived xenograft models of multiple myeloma reveals selection of multiple pre-existing high risk clones
Nathan J. Becker, En-Ze Liu, Riya Sharma, Parvathi Sudha +22 more
2026bioRxiv0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Abu Zaid×13
Invite
M. Abu Zaid — researcher profile on SciRah
A. Suvannasankha×13
Invite
A. Suvannasankha — researcher profile on SciRah
R. Rifkin×12
Invite
R. Rifkin — researcher profile on SciRah
Parvathi Sudha×12
Invite
Parvathi Sudha — researcher profile on SciRah

×9

Invite

En-Ze Liu — researcher profile on SciRah

Invite

Kelvin Lee — researcher profile on SciRah

Invite

B. Durie — researcher profile on SciRah

S. Ailawadhi×8

Invite

S. Ailawadhi — researcher profile on SciRah

Brian A. Walker×8

Invite

Brian A. Walker — researcher profile on SciRah

Invite

M. Narang — researcher profile on SciRah

Invite

H. Terebelo — researcher profile on SciRah

Invite

K. Toomey — researcher profile on SciRah